Saturday, March 21, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

Europe facing 500,000 more Covid deaths by February, WHO warns

Europe is facing a potentially devastating winter that could see half a million people die with Covid-19, the World Health Organization (WHO) warned, as it sounded the alarm over a surge in cases and bemoaned stuttering vaccination rollouts on parts of the continent.

Much of Europe is battling spikes in infections, with Germany on Thursday reporting its highest number of daily new cases since the pandemic began. And in a dire new warning, WHO regional director Hans Kluge said the pace of transmission across the region was of “grave concern.” “We are, once again, at the epicenter,” Kluge said in a statement.

Source: CNN

https://www.cnn.com/2021/11/04/europe/europe-covid-winter-who-projection-intl/index.html

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

Policy Shift in Peptide Regulation

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!